Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

Leaders

Leading CEO spearheads support for cancer research & tech

Published

on

In the fight against cancer, funding for early-stage researchers and early-stage biotechnology is critical

Leading CEO of Cure Brain Cancer Foundation, Lance Kawaguchi, is spearheading support for new innovation to beat cancer.

Kawaguchi firmly believes that there must be more support for early-stage researchers and early-stage biotechnology. He knows that solving this problem can ultimately change the way cancer is approached.

“I wanted to make sure we can change the paradigm, so we can get money to treatments and also to researchers as quick as possible.”

lance kawaguchi, ceo, cure brain cancer foundation

Leading experts collaborate on cancer cure mission

Ticker’s Holly Stearnes sat down with Kawaguchi, alongside Professor Webster Cavenee and Dr. Alfred Yung. Together, they spoke about the importance of funding for early-stage researchers and early-stage biotechnology.

Cavenee is the Chairperson of our Scientific Advisory Committee & Director at the Ludwig Cancer Research, San Diego.

He has fundamentally changed the way scientists think about the onset of cancer and its progression. 

Yung is an integral part of Neuro-Oncology at the MD Anderson Cancer Center. He is an expert in clinical research and treatment of glioblastoma multiforme.

Yung is also a 17-year cancer survivor and was recently named to the Blue Ribbon panel of experts selected to advise the Beau Biden Cancer Moonshot.

Investing in early-stage researchers

Researchers are an integral part of the fight against all cancers. They work tirelessly to find a cure or treatment to ensure a better outcome for those who have fallen victim to the disease.

However, far too often, many early-career researchers miss out on critical funding to enhance and enable their remarkable work.

Many early-stage researchers are exposed to discrimination in the industry and frequently denied access to grants. Instead, grants are mostly given to late-career researchers.

The hierarchy in the industry means that up and coming researchers and some of the best minds in the world regularly get overlooked.

However, these minds and fresh ideas are the key to trying new innovations and potentially a cure for a disease that impacts millions of people every day.

The future depends on rising researchers and the innovation they bring.

Cure Brain Cancer Foundation is transforming the way cancer is approached and injecting much-needed awareness. Cancer is more than just a cause, it’s a movement.

“Researchers are the hardest working people. I want to make sure they have stability of funding… There’s a fundamental flaw in how we support early researchers.”

lance kawaguchi

Challenges for early-stage biotechnology

Biotechnology is the key to finding a cure for cancer. However, its innovative ideas don’t always make it to fruition because they face enormous setbacks within the industry.

Early-stage biotechs need funding to begin and continue to operate. The market in general is saturated and extremely hard to eventuate.

“We need to take a different lens… Where we can focus on the return on investment but also on the return on social impact.”

lance kawaguchi

Combatting early stages of a new biotechnology company can be difficult.

However, focusing on quality science, strategic management, securing funding, staffing, and regulatory compliance can increase the chances of success.  

“You can think about how cancer is investigated as if it’s a funnel… What we want to do is fill the funnel.

By that I mean new ideas, from multiple fields… We need to make the top of the funnel wider.”

Professor webster cavenee

Cancer knows no boundaries

Yung treated U.S. President Joe Biden’s oldest son, Beau Biden, before his death of brain cancer, aged 46.

Yung has been recognised by the Biden family, for his attempt to save Beau’s life.

The Biden administration launched the Cancer Moonshot’ initiative in a bid to halve the rate of cancer deaths by 2047. The President made mention of Yung when launching the initiative.

“See that doctor on the end there?

That’s the man who spent 18 months trying to save our son’s life. Doctor, I love you. The whole family loves you.”

Joe biden, u.s. President
(AP Photo/Evan Vucci)

Trusting in CBCF

Lead by Kawaguchi, Cure Brain Cancer Foundation, is adding urgency to the fight against cancer.

They’re putting processes in place to give funding to early-stage researchers and early-stage biotechs, who have the ability to innovate the way cancer is approached.

Both Yung and Cavenee are highly respected in cancer research and have chosen to partner with Kawaguchi in his mission to find a cure for brain cancer.

“His keen interest on innovation and out of the box thinking… He is a move and shaker and it is a privilege to partner with him in this endeavour.”

Dr. Alfred yung

“Lance is on a mission for cancer patients, and that’s why I partnered with him.”

Professor webster cavenee

Leaders

AI and automation reshape future tech careers

AI transformation reshapes tech careers, creating demand for new roles and skills, says Promise Akwaowo from Royal Mail Group

Published

on

AI transformation reshapes tech careers, creating demand for new roles and skills, says Promise Akwaowo from Royal Mail Group

In Short:
– AI is rapidly changing tech careers, creating new roles like AI business analyst and AI engineer.
– ICT professionals need to develop skills in AI, data literacy, and cybersecurity to stay competitive.

Promise Akwaowo, CBAP®, is a business analyst and product owner working across enterprise automation, data governance, and large-scale digital transformation.

In this discussion, Promise highlights how AI and automation are rapidly reshaping tech careers, creating entirely new roles across the global ICT landscape. According to him, AI has become a core requirement in tech hiring, with around 78% of job listings now referencing artificial intelligence.

Roles such as AI business analysts and AI engineers are growing quickly, with seven of the ten fastest-growing tech jobs linked to AI. At the same time, rising concerns around data use, privacy, and trust are driving demand for governance specialists and analysts focused on AI ethics.

Data literacy

To remain competitive, ICT professionals are expected to expand their skill sets, with data literacy, cloud fluency, cybersecurity, and automation projected to be essential by 2026. For businesses, investing in AI-ready talent is key to improving efficiency and supporting long-term growth.

Promise has also worked across sectors, including logistics, higher education, and investor relations technology, focusing on turning complex concepts into scalable digital products. His projects often apply human-centred design principles while emphasising clearly defined performance outcomes.

 


Download the Ticker app

Continue Reading

Leaders

Investing in shares: Insights for fluctuating markets

Jabin Hallihan discusses share investing strategies and market insights from Family Financial Solutions ahead of 2026

Published

on

Jabin Hallihan discusses share investing strategies and market insights from Family Financial Solutions ahead of 2026

In Short:
– Jabin Hallihan advises diversifying portfolios and buying shares during fluctuating markets, emphasising long-term strategies.
– He highlights AI and copper as promising sectors, predicting strong earnings for BHP in 2026.

Jabin Hallihan from Family Financial Solutions shares expert advice on investing in shares as markets fluctuate. He highlights the difficulty of timing the market and echoes Warren Buffett’s philosophy: the best time to buy shares was yesterday. For investors, understanding market timing is crucial.

The ASX 200 is currently valued at around 8,500, slightly below its October peak of 9,000. With a price-to-earnings ratio near 17, above the long-term average of 14, expected earnings for the coming year look promising at 10–11%. Hallihan emphasises the importance of a diversified portfolio and identifies AI as a continuing investment theme, while high-quality stocks like BHP and Rio Tinto offer resilience during downturns.

For funding acquisitions, consider taking profits from outperforming US tech stocks and reallocating into leading Australian resource companies. Looking into 2026, AI investment by major firms is set to accelerate, and the Australian mining sector—particularly copper—could provide significant upside. Jabin Hallihan can be contacted through Family Financial Solutions in Heatherton, Victoria.


Download the Ticker app

Continue Reading

Leaders

Innovative plant-based smoked salmon launching in January

Published

on

Baruch Dach discusses SimpliiGood’s innovative plant-based smoked salmon made from solar-powered spirulina aimed at tackling climate change

In Short:
– Baruch Dach founded SimpliiGood, focusing on sustainable protein from solar-powered, desert-grown spirulina for plant-based smoked salmon.
– The company targets the restaurant industry and will launch its product in Israel, followed by Europe and the US.

SimpliiGood is redefining sustainable protein by turning solar-powered, desert-grown spirulina into whole-cut alternatives like plant-based smoked salmon.

Founder and CTO Baruch Dach explains how spirulina’s unique biology enables it to efficiently convert solar energy into complete protein while maintaining a structure similar to muscle fiber.

Baruch breaks down how the controlled desert environment, powered by renewable energy, allows for scalable, clean, and climate-resilient food production. The conversation dives into how spirulina’s natural properties make it an ideal base for delicate proteins like fish, something many plant-based brands struggle to replicate.

With spirulina at the centre of their innovation, SimpliiGood is pushing the boundaries of clean-label, nutrient-rich protein alternatives.

 SimpliiGood’s smoked salmon is set to launch in January, targeting restaurants, bagels, and sushi markets. Initial sales will be in Israel, expanding to Western Europe, with plans to register with the FDA for a US launch.

The company positions itself as an ingredient supplier in the plant-based and hybrid markets, aiming to provide products that create a satisfying consumer experience, whether they are entirely plant-based or contain small amounts of fish or meat.

For more information, visit SimpliiGood

Ahron Young traveled to Israel as a guest of the Foreign Ministry climate delegation.
Download the Ticker app

Continue Reading

Trending Now